Second generation direct acting antivirals (DAAs) drastically changed the landscape of chronic HCV (CHCV). Aim of this paper was to assess the effectiveness of DAAs, also looking at the demographic characteristics of subjects enrolled.
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results / Scotto, Riccardo; Buonomo, Antonio Riccardo; De Pascalis, Stefania; Nerilli, Mariagiovanna; Pinchera, Biagio; Staiano, Laura; Mercinelli, Simona; Cattaneo, Letizia; Stanzione, Maria; Stornaiuolo, Gianfranca; Martini, Salvatore; Messina, Vincenzo; Coppola, Carmine; Coppola, Nicola; Gentile, Ivan. - In: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. - ISSN 1747-4124. - 15:9(2021), pp. 1057-1063. [10.1080/17474124.2021.1890029]
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results
Scotto, Riccardo;Buonomo, Antonio Riccardo;Nerilli, Mariagiovanna;Pinchera, Biagio;Staiano, Laura;Mercinelli, Simona;Cattaneo, Letizia;Coppola, Nicola;Gentile, Ivan
2021
Abstract
Second generation direct acting antivirals (DAAs) drastically changed the landscape of chronic HCV (CHCV). Aim of this paper was to assess the effectiveness of DAAs, also looking at the demographic characteristics of subjects enrolled.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
